Skip to content
TrialScanner

NCT03913949

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

Phase 1Active, not recruitingAAPGLead

Registry record

Lead sponsor
Ascentage Pharma Group Inc.
Conditions
Chronic Lymphocytic Leukemia; Non Hodgkin Lymphoma
Primary completion
Oct 20, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03913949 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03913949: A Study to Evaluate the... | TrialScanner